Revolutionary Cancer Detection Technique Uses Whole-Body MRI Scans to Identify Tiny Traces of Myeloma

Strategic Insights -

Air Vice-Marshal Fin Monahan, a 57-year-old father of three, was diagnosed with myeloma in 2009 while serving in the RAF. He has since relapsed twice, but thanks to whole-body MRI scans, his cancer was detected much earlier than would have been possible with a traditional CT scan. This cutting-edge treatment not only extended his life but also allowed him to continue serving his country. Researchers have now found a new way to detect tiny traces of cancer, which could help "revolutionise" care for patients with a certain form of blood cancer.

Key Takeaways:

  • A whole-body MRI scan can detect minuscule amounts of myeloma even when traditional tests show no signs of cancer.
  • The study, led by Professor Christina Messiou, found that one in three patients had signs of residual disease on whole-body MRI after treatment.
  • Overall survival was significantly shorter in those with positive MRI findings, highlighting the importance of early detection.
  • The technique provides valuable information about how well the myeloma has responded to treatment, which traditional tests may miss.
  • Whole-body MRI scans use no radiation, making them a safer alternative to other imaging methods.
  • Myeloma is a type of blood cancer that affects more than one part of the body and is not considered curable but can be controlled with treatment.
  • Around 6,200 people are diagnosed with myeloma each year in the UK, and there are approximately 33,000 people living with the condition.

Statistics:

  • 70 myeloma patients were tracked in the study, all of whom were having a stem cell transplant.
  • One in three patients had signs of residual disease on whole-body MRI after treatment.
  • Overall survival was significantly shorter in those with positive MRI findings.
  • Myeloma is diagnosed approximately 6,200 times per year in the UK.
  • There are around 33,000 people living with myeloma in the UK.

Sources:

  • The Royal Marsden NHS Foundation Trust and The Institute of Cancer Research, London
  • Blood Cancer Journal
  • Myeloma UK